Clinical Research and Development of Tuberculosis Diagnostics: Moving From Silos to Synergy

被引:25
|
作者
Nahid, Payam [1 ,2 ]
Kim, Peter S. [3 ]
Evans, Carlton A. [4 ,5 ]
Alland, David [6 ]
Barer, Michael [7 ]
Diefenbach, Jane [8 ]
Ellner, Jerrold [9 ]
Hafner, Richard [3 ]
Hamilton, Carol Dukes [10 ]
Iademarco, Michael F. [14 ]
Ireton, Gregory [11 ]
Kimerling, Michael E. [12 ]
Lienhardt, Christian [13 ]
MacKenzie, William R. [14 ]
Murray, Megan [15 ]
Perkins, Mark D. [16 ]
Posey, Jamie E. [14 ]
Roberts, Teri [17 ]
Sizemore, Christine [18 ]
Stevens, Wendy S. [19 ,20 ]
Via, Laura [21 ]
Williams, Sharon D. [3 ]
Yew, Wing W. [22 ]
Swindells, Susan [23 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94110 USA
[3] NIAID, Div Aids, Bethesda, MD 20892 USA
[4] Univ Peruana Cayetano Heredia, IFHAD, Lima, Peru
[5] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London SW7 2AZ, England
[6] Univ Med & Dent New Jersey, Dept Med, Ctr Emerging & Reemerging Pathogens, Newark, NJ 07103 USA
[7] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 7RH, Leics, England
[8] PharmaStat LLC, Newark, CA USA
[9] Boston Univ Sch Med & Med Ctr, Dept Med, Infect Dis Sect, Boston, MA USA
[10] Family Hlth Int, Durham, NC USA
[11] Bill & Melinda Gates Fdn, Infect Dis Res Inst, Seattle, WA USA
[12] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA
[13] WHO, Stop TB Partnership, CH-1211 Geneva, Switzerland
[14] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA
[15] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[16] Fdn Innovat New Diagnost, Geneva, Switzerland
[17] Med San Frontieres, Campaign Access Essential Med, Geneva, Switzerland
[18] NIAID, Div Microbiol & Infect Dis, Bethesda, MD 20892 USA
[19] Univ Witwatersrand, Johannesburg, South Africa
[20] Natl Hlth Lab Serv, Johannesburg, South Africa
[21] NIAID, Lab Clin Infect Dis, TB Res Sect, Bethesda, MD 20892 USA
[22] Hong Kong TB Chest & Heart Dis Assoc, Hong Kong, Hong Kong, Peoples R China
[23] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA
来源
基金
英国惠康基金;
关键词
MEDIATED ISOTHERMAL AMPLIFICATION; DRUG-SUSCEPTIBILITY ASSAY; SPUTUM SMEAR MICROSCOPY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; MOLECULAR-DETECTION; LAM-ELISA; URINE; ACCURACY;
D O I
10.1093/infdis/jis194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development, evaluation, and implementation of new and improved diagnostics have been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis researchers and clinicians alike. These needs exist in international and domestic settings and in adult and pediatric populations. Experts in tuberculosis and HIV care, researchers, healthcare providers, public health experts, and industry representatives, as well as representatives of pertinent US federal agencies (Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, United States Agency for International Development) assembled at a workshop proposed by the Diagnostics Working Group of the Federal Tuberculosis Taskforce to review the state of tuberculosis diagnostics development in adult and pediatric populations.
引用
收藏
页码:S159 / S168
页数:10
相关论文
共 50 条
  • [1] Interdisciplinary evidence-based practice: Moving from silos to synergy
    Newhouse, Robin P.
    Spring, Bonnie
    NURSING OUTLOOK, 2010, 58 (06) : 309 - 317
  • [2] Moving beyond disciplinary silos: The potential for transdisciplinary research in Sport for Development
    Whitleyl, Meredith A.
    Collison-Randall, Holly
    Wright, Paul M.
    Darnell, Simon C.
    Schulenkorf, Nico
    Kneel, Eric
    Holt, Nicholas L.
    Richards, Justin
    JOURNAL OF SPORT FOR DEVELOPMENT, 2022, 10 (02): : 1 - 25
  • [3] Moving toward Tuberculosis Elimination Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection
    Keshavjee, Salmaan
    Amanullah, Farhana
    Cattamanchi, Adithya
    Chaisson, Richard
    Dobos, Karen M.
    Fox, Gregory J.
    Gendelman, Howard E.
    Gordon, Richard
    Hesseling, Anneke
    Hoi Le Van
    Kampmann, Beate
    Kana, Bavesh
    Khuller, Gopal
    Lewinsohn, David M.
    Lewinsohn, Deborah A.
    Lin, Philiana Ling
    Lu, Lenette Lin
    Maartens, Gary
    Owen, Andrew
    Protopopova, Marina
    Rengarajan, Jyothi
    Rubin, Eric
    Salgame, Padmini
    Schurr, Erwin
    Seddon, James A.
    Swindells, Susan
    Tobin, David M.
    Udwadia, Zarir
    Walzl, Gerhard
    Srinivasan, Sudha
    Rustomjee, Roxana
    Nahid, Payam
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (05) : 564 - 571
  • [4] Bispecific Antibodies are Moving from Research to Clinical Development
    Mirasol, Feliza
    BIOPHARM INTERNATIONAL, 2022, 35 (06) : 16 - 20
  • [5] Moving from Silos to Systems in Black Women's Health Research
    Kumanyika, Shiriki
    MERIDIANS-FEMINISM RACE TRANSNATIONALISM, 2018, 16 (02) : 238 - 252
  • [6] Moving out of silos for obesity research and treatment
    Nadler, Evan P.
    LANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (04): : 224 - 225
  • [7] From silos to a critical path of new agent development: A paradigm to revolutionize clinical research
    Benson, Al B., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1924 - 1925
  • [8] New research and development strategy for tuberculosis diagnostics urgently needed
    Batz, Hans-Georg
    Casenghi, Martina
    Cooke, Graham S.
    Hargreaves, Sally
    Reid, Steven D.
    Syed, Javid
    LANCET INFECTIOUS DISEASES, 2012, 12 (08): : 584 - 585
  • [9] Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
    Henrik Zetterberg
    Kaj Blennow
    Molecular Neurodegeneration, 16
  • [10] Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics
    Zetterberg, Henrik
    Blennow, Kaj
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)